Medizone Intl. (fka MZEIQ)

[goforthebet]

Medizone's AsepticSure Disinfection Technology Gets Favorable Peer Review

http://futuresource.quote.com/quotes/food/story.action;jsessionid=abcI6xhVjTZS-_LFCqJ-s?moreRelatedAnchor=%23related&id=CLM132c1463

05/12/11 00:46:52 EDT

May 12, 2011 (Close-Up Media via COMTEX News Network) --
Medizone International, Inc. said that the highly efficacious properties of its newly-developed disinfection and decontamination technology, AsepticSure, have received mainstream validation by way of publication in the American Journal of Infection Control.

In a release, the Company noted:

The research paper co-authored by Drs Dick Zoutman, MD, FRCPC; Michael Shannon, MA, MD, MSc; and Arkady Mandel MD, PhD, DSc - reveals how Medizone's AsepticSure system, using a proprietary ozone-based process, creates a highly reactive oxidative vapor with high-level antimicrobial properties across a broad array of infectious disease-causing pathogens.

The methodology outlined in the peer review article involves the blending of Medizone's patent pending combination of low dosage ozone gas with hydrogen peroxide vapor at specific relative humidity.

Full decontamination i.e. 100 percent microbial kill-rates measured as minimal reduction rates ranging from 6 7.9 log was achieved in all bacteria and spores tested on steel discs in a test chamber as well as on cotton fabric. The same degree of efficacy was repeated in Medizone's 81 cubic meter full scale test room and then duplicated in a 90 cubic meter hospital room.

Dr Shannon, President and Director of Medical Affairs for Medizone said "This synergistic effect was noted for all 4 vegetative bacteria we tested MRSA, VRE, E. coli and P. aeruginosa to the point where 100 percent decontamination levels were consistently achieved within 30 minutes of exposure.

"Bacterial kill-rates of this magnitude are unprecedented in relation to the relatively low concentration of ozone and short durations used. So too are the 100 percent kill-rates achieved with the spores of C. difficile and B. subtilis (the study surrogate for Anthrax) NB: 6 7 log reductions were attained under identical test conditions with only slightly longer exposure periods of 45 90 minutes respectively."

CEO Edwin Marshall, added, "The publication of these findings in a prestigious peer review journal is a pivotal moment for the future of AsepticSure. It is also a historic moment in the 125 year long search for an ozone-based disinfectant that not only meets all mainstream standards of efficacy and safety, but outperforms them!

..........................................